Literature DB >> 17561801

Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds.

Tiffany L Sellaro1, Anjani K Ravindra, Donna Beer Stolz, Stephen F Badylak.   

Abstract

Sinusoidal endothelial cells (SECs) are notoriously difficult to culture in vitro. SECs represent a highly specialized endothelial cell (EC) population, and traditional methods of SEC isolation from the liver initiate a process of SEC dedifferentiation. Acellular extracellular matrix (ECM) scaffolds were investigated in a physiologically relevant in vitro culture model for their ability to maintain SEC phenotype. The cell culture model used SECs only or a coculture of SECs with hepatocytes on ECM substrates derived from the liver (L-ECM), bladder (UBM-ECM), or small intestine submucosa (SIS-ECM). The effect of the ECM substrate upon SEC dedifferentiation was evaluated using scanning electron microscopy (SEM) and confocal microscopy. When SECs alone were cultured on uncoated glass slides, collagen I, UBM-ECM, or SIS-ECM, SECs showed signs of dedifferentiation after 1 day. In contrast, SECs alone cultured on L-ECM maintained their differentiated phenotype for at least 3 days, indicated by the presence of many fenestrations on SEC surface, expression of anti-rat hepatic sinusoidal endothelial cells mouse IgG MoAb (SE-1), and lack of expression of CD31. When SECs were cocultured with hepatocytes on any of the ECM scaffolds, the SECs maintained a near-normal fenestrated phenotype for at least 1 day. However, SEM revealed that the shape, size, frequency, and organization of the fenestrations varied greatly depending on ECM source. At all time points, SECs cocultured with hepatocytes on L-ECM maintained the greatest degree of differentiation. The present study demonstrated that the acellular ECM scaffold derived from the liver maintained SEC differentiation in culture longer than any of the tested substrate materials. The replacement of complex tissues and 3-dimensional organs may require specialized scaffolds to support multiple, functional cell phenotypes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17561801     DOI: 10.1089/ten.2006.0437

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  84 in total

1.  Right ventricular outflow tract repair with a cardiac biologic scaffold.

Authors:  John M Wainwright; Ryotaro Hashizume; Kazuro L Fujimoto; Nathaniel T Remlinger; Colin Pesyna; William R Wagner; Kimimasa Tobita; Thomas W Gilbert; Stephen F Badylak
Journal:  Cells Tissues Organs       Date:  2011-10-24       Impact factor: 2.481

2.  Biologic scaffold composed of skeletal muscle extracellular matrix.

Authors:  Matthew T Wolf; Kerry A Daly; Janet E Reing; Stephen F Badylak
Journal:  Biomaterials       Date:  2012-01-20       Impact factor: 12.479

3.  Comparison of three methods for the derivation of a biologic scaffold composed of adipose tissue extracellular matrix.

Authors:  Bryan N Brown; John M Freund; Li Han; J Peter Rubin; Janet E Reing; Eric M Jeffries; Mathew T Wolf; Stephen Tottey; Christopher A Barnes; Buddy D Ratner; Stephen F Badylak
Journal:  Tissue Eng Part C Methods       Date:  2011-02-05       Impact factor: 3.056

4.  Evaluation of the biocompatibility and mechanical properties of xenogeneic (porcine) extracellular matrix (ECM) scaffold for pelvic reconstruction.

Authors:  Lubin Liu; Deng Li; Yanzhou Wang; Huicheng Xu; Liangpeng Ge; Zhiqing Liang
Journal:  Int Urogynecol J       Date:  2010-10-09       Impact factor: 2.894

5.  The effects of processing methods upon mechanical and biologic properties of porcine dermal extracellular matrix scaffolds.

Authors:  Janet E Reing; Bryan N Brown; Kerry A Daly; John M Freund; Thomas W Gilbert; Susan X Hsiong; Alexander Huber; Karen E Kullas; Stephen Tottey; Matthew T Wolf; Stephen F Badylak
Journal:  Biomaterials       Date:  2010-08-21       Impact factor: 12.479

6.  Producing organs in the laboratory.

Authors:  Mark E Furth; Anthony Atala
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

7.  Urinary bladder matrix promotes site appropriate tissue formation following right ventricle outflow tract repair.

Authors:  Nathaniel T Remlinger; Thomas W Gilbert; Masahiro Yoshida; Brogan N Guest; Ryotaro Hashizume; Michelle L Weaver; William R Wagner; Bryan N Brown; Kimimasa Tobita; Peter D Wearden
Journal:  Organogenesis       Date:  2013-06-25       Impact factor: 2.500

8.  Preparation of cardiac extracellular matrix from an intact porcine heart.

Authors:  John M Wainwright; Caitlin A Czajka; Urvi B Patel; Donald O Freytes; Kimimasa Tobita; Thomas W Gilbert; Stephen F Badylak
Journal:  Tissue Eng Part C Methods       Date:  2010-06       Impact factor: 3.056

9.  Improving functional re-endothelialization of acellular liver scaffold using REDV cell-binding domain.

Authors:  Julie Devalliere; Yibin Chen; Kevin Dooley; Martin L Yarmush; Basak E Uygun
Journal:  Acta Biomater       Date:  2018-07-31       Impact factor: 8.947

10.  Chemoattractant activity of degradation products of fetal and adult skin extracellular matrix for keratinocyte progenitor cells.

Authors:  Ellen P Brennan; Xiao-Han Tang; Ann M Stewart-Akers; Lorraine J Gudas; Stephen F Badylak
Journal:  J Tissue Eng Regen Med       Date:  2008-12       Impact factor: 3.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.